Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Tirapazamine by Teclison for Gastroesophageal (GE) Junction Carcinomas: Likelihood of Approval
Tirapazamine is under clinical development by Teclison and currently in Phase II for Gastroesophageal (GE) Junction Carcinomas. According to GlobalData,...
Data Insights
Tirapazamine by Teclison for Hepatocellular Carcinoma: Likelihood of Approval
Tirapazamine is under clinical development by Teclison and currently in Phase II for Hepatocellular Carcinoma. According to GlobalData, Phase II...